T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure

被引:0
|
作者
Carina Gröschel
André Sasse
Charlotte Röhrborn
Sebastian Monecke
Michael Didié
Leslie Elsner
Vanessa Kruse
Gertrude Bunt
Andrew H. Lichtman
Karl Toischer
Wolfram-Hubertus Zimmermann
Gerd Hasenfuß
Ralf Dressel
机构
[1] Institute of Cellular and Molecular Immunology,
[2] University Medical Center Göttingen,undefined
[3] DZHK (German Center for Cardiovascular Research),undefined
[4] partner site Göttingen,undefined
[5] Institute of Pharmacology and Toxicology,undefined
[6] University Medical Center Göttingen,undefined
[7] Department of Cardiology and Pneumology,undefined
[8] University Medical Center Göttingen,undefined
[9] Clinical Optical Microscopy,undefined
[10] Department of Neuropathology,undefined
[11] University Medical Center Göttingen,undefined
[12] Department of Pathology,undefined
[13] Brigham and Women’s Hospital,undefined
[14] Harvard Medical School,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We investigated whether CD4+-T cells with specificity for an antigen in cardiomyocytes promote the progression from hypertrophy to heart failure in mice with increased pressure load due to transverse aortic constriction (TAC). OT-II mice expressing a transgenic T cell receptor (TCR) with specificity for ovalbumin (OVA) on CD4+-T cells and cMy-mOVA mice expressing OVA on cardiomyocytes were crossed. The resulting cMy-mOVA-OT-II mice did not display signs of spontaneous autoimmunity despite the fact that their OVA-specific CD4+-T cells were not anergic. After TAC, progression to heart failure was significantly accelerated in cMy-mOVA-OT-II compared to cMy-mOVA mice. No OVA-specific antibodies were induced in response to TAC in cMy-mOVA-OT-II mice, yet more CD3+ T cells infiltrated their myocardium when compared with TAC-operated cMy-mOVA mice. Systemically, the proportion of activated CD4+-T cells with a Th1 and Th17 cytokine profile was increased in cMy-mOVA-OT-II mice after TAC. Thus, T helper cells with specificity for an antigen in cardiomyocytes can directly promote the progression of heart failure in response to pressure overload independently of autoantibodies.
引用
收藏
相关论文
共 50 条
  • [21] Interleukin-12 alpha deficiency attenuates pressure overload-induced cardiac inflammation, hypertrophy, dysfunction, and heart failure progression
    Bhattarai, Umesh
    He, Xiaochen
    Xu, Rui
    Liu, Xiaoguang
    Pan, Lihong
    Sun, Yuxiang
    Chen, Jian-Xiong
    Chen, Yingjie
    PHYSIOLOGY, 2023, 38
  • [22] Attenuation of volume overload-induced cardiac hypertrophy and heart failure in rats
    Zhang, WH
    Rathi, SS
    Dhalla, NS
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (07) : A12 - A12
  • [23] LuQi formula ameliorates pressure overload-induced heart failure by regulating macrophages and regulatory T cells
    Wang, Xinting
    Liu, Qian
    Cheng, Peipei
    Yang, Tianshu
    Zhao, Tingyao
    Liu, Meng
    Dai, Enrui
    Sha, Wanjing
    Yuan, Jinfeng
    Rong, Jingfeng
    Qu, Huiyan
    Zhou, Hua
    PHYTOMEDICINE, 2025, 141
  • [24] Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice
    Weng, Li-qing
    Zhang, Wen-bin
    Ye, Yong
    Yin, Pei-pei
    Yuan, Jie
    Wang, Xing-xu
    Kang, Le
    Jiang, Sha-sha
    You, Jie-yun
    Wu, Jian
    Gong, Hui
    Ge, Jun-bo
    Zou, Yun-zeng
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (08) : 1005 - 1014
  • [25] Calpain activation is involved in the pressure overload-induced hypertrophy in the mouse heart
    Fukunaga, K
    Hashimoto, M
    Shioda, N
    Hachimura, E
    Shirasaki, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 136P - 136P
  • [26] Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice
    Li-qing Weng
    Wen-bin Zhang
    Yong Ye
    Pei-pei Yin
    Jie Yuan
    Xing-xu Wang
    Le Kang
    Sha-sha Jiang
    Jie-yun You
    Jian Wu
    Hui Gong
    Jun-bo Ge
    Yun-zeng Zou
    Acta Pharmacologica Sinica, 2014, 35 : 1005 - 1014
  • [27] Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy
    Iorga, Andrea
    Li, Jingyuan
    Sharma, Salil
    Umar, Soban
    Bopassa, Jean C.
    Nadadur, Rangarajan D.
    Centala, Alexander
    Ren, Shuxun
    Saito, Tomoaki
    Toro, Ligia
    Wang, Yibin
    Stefani, Enrico
    Eghbali, Mansoureh
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01): : 1 - 12
  • [28] Effects of Pitavastatin on Pressure Overload-Induced Heart Failure in Mice
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    CIRCULATION JOURNAL, 2012, 76 (05) : 1159 - 1168
  • [29] Rethinking Protein Acetylation in Pressure Overload-Induced Heart Failure
    Scott, Iain
    Sack, Michael N.
    CIRCULATION RESEARCH, 2020, 127 (08) : 1109 - 1111
  • [30] EFFECT OF PITAVASTATIN ON PRESSURE OVERLOAD-INDUCED HEART FAILURE IN MICE
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Takano, Hiroyuki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1062 - E1062